Simultaneous production of rhamnolipids, 2-alkyl-4-hydroxyquinolines, and phenazines by clinical isolates of Pseudomonas aeruginosa.
Of 72 clinical isolates of Pseudomonas aeruginosa examined for simultaneous production of secondary metabolites, 86% produced 2-alkyl-4-hydroxyquinolines, 75% produced rhamnolipids, and 58% produced phenazines, including pyocyanin. Whereas isolates producing two or one constituted smaller groups, 39% released all three metabolites. Metabolite production did not appear to influence site of infection.
D006017:Glycolipids / Q000096:biosynthesis*; D006801:Humans; D006912:Hydroxyquinolines / Q000096:biosynthesis*; D010619:Phenazines / Q000378:metabolism*; D011552:Pseudomonas Infections / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000378:metabolism*; D012210:Rhamnose / Q000096:biosynthesis
D006017:Glycolipids; D006912:Hydroxyquinolines; D010619:Phenazines; D012210:Rhamnose